The groundbreaking creation of the world’s first commercial hybrid of silicon circuitry and human brain cells is set to revolutionize the field of medical research. Known as the CL1 computer, this innovative biological machine is the result of a collaboration between Australian biotech startup Cortical Labs and UK company bit.bio.
The CL1 computer is made up of 800,000 neurons grown on a silicon chip, along with their life-support system. While it may not rival the processing power of today’s most advanced computers, the CL1 system boasts a significant advantage in its energy efficiency. Unlike traditional AI centers that consume massive amounts of energy, a rack of CL1 machines only uses 1,000 watts and is capable of real-time adaptation and learning.
According to Cortical Labs, the neurons in the CL1 computer are self-programming and incredibly flexible, drawing on billions of years of evolution. This biological and synthetic hybrid has shown promising performance when compared to machine learning algorithms in various tests conducted by neuroscientist Brett Kagan and his team.
Users of the CL1 computer can send code directly to the system of neurons, which can respond to electrical signals almost instantly. These signals serve as bits of information that the cells can interpret and act upon. This capability opens up a world of possibilities for research in neuroscience and other fields.
One of the most exciting applications of the CL1 computer is its potential for drug testing and research. By studying how epileptic cells respond to different treatments, researchers can gain valuable insights into the effects of various medications on the brain. Additionally, the neurons used in the CL1 computer are derived from skin and blood samples provided by adult human donors, adding a personalized touch to this cutting-edge technology.
While there are still limitations to be addressed, such as the lifespan of the neurons and their ability to survive for only six months, the energy-saving potential of the CL1 computer makes it a promising avenue for further development. The first units are set to ship soon, with a price tag of $35,000 each, or remote access can be rented for $300 per week.
Overall, the CL1 computer represents a significant step forward in the integration of biological and synthetic systems, with far-reaching implications for medical research and beyond. Stay tuned for more updates on this groundbreaking technology.
